EIGR
Eiger BioPharmaceuticals, Inc.
EIGR
EIGR
Delisted
EIGR was delisted on the 10th of April, 2024.
24 hedge funds and large institutions have $3.19M invested in Eiger BioPharmaceuticals, Inc. in 2024 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 3 increasing their positions, 15 reducing their positions, and 21 closing their positions.
New
Increased
Maintained
Reduced
Closed
less capital invested
Capital invested by funds: $ → $
less funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less first-time investments, than exits
New positions opened: | Existing positions closed:
Holders
24
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$450K | |
| 2 | +$170K | |
| 3 | +$6.7K | |
| 4 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
+$1.75K |
| 5 |
Osaic Holdings
Scottsdale,
Arizona
|
+$365 |
Top Sellers
| 1 | -$202K | |
| 2 | -$163K | |
| 3 | -$33K | |
| 4 |
Northern Trust
Chicago,
Illinois
|
-$25.2K |
| 5 |
Acadian Asset Management
Boston,
Massachusetts
|
-$22.3K |